Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

15.35
-0.2800-1.79%
Post-market: 15.350.00000.00%16:37 EDT
Volume:1.39M
Turnover:21.43M
Market Cap:1.79B
PE:-11.73
High:16.07
Open:15.26
Low:15.10
Close:15.63
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:1.35
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.29
PE(LYR):-12.56

Loading ...

Novocure Shares Climb After Company Posts Higher 1Q Revenue, Raises Full-Year Outlook

Dow Jones
·
May 01

Stock Track | NovoCure Soars 25.78% Intraday on Q1 Revenue Beat and Raised 2026 Guidance

Stock Track
·
Apr 30

Novocure Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 30

Novocure reports Q1 EPS (62c), consensus (51c)

TIPRANKS
·
Apr 30

GUIDANCE: (NVCR) NovoCure Expects Full Year 2026 Revenue Range $690M - $710M, vs. FactSet Est of $694.7M

MT Newswires Live
·
Apr 30

Earnings Flash (NVCR) NovoCure Posts Q1 Net Loss $0.62 a Share, vs. FactSet Est of $0.51 Loss

MT Newswires Live
·
Apr 30

Stock Track | NovoCure Soars 13.08% in Pre-Market on Q1 Revenue Beat and Raised 2026 Guidance

Stock Track
·
Apr 30

Novocure Q1 Revenue USD 174.055 Million Vs. IBES Estimate USD 167.9 Million

Reuters
·
Apr 30

Novocure Q1 FY26 net loss widens to $71.1 million; revenue rises 12% to $174.1 million

Reuters
·
Apr 30

NovoCure Q1 EPS $(0.62) Misses $(0.51) Estimate, Sales $174.055M Beat $167.867M Estimate

Benzinga Earnings
·
Apr 30

Novocure Q1 Pretax Profit USD -69.258 Million

THOMSON REUTERS
·
Apr 30

Novocure Q1 Gross Profit USD 135.126 Million

THOMSON REUTERS
·
Apr 30

Novocure Ltd - Raises 2026 Net Revenue Guidance to $690 Mln-$710 Mln

THOMSON REUTERS
·
Apr 30

Novocure Ltd expected to post a loss of 51 cents a share - Earnings Preview

Reuters
·
Apr 28

Earning Preview: NovoCure this quarter’s revenue is expected to increase by 14.50%, and institutional views are bullish

Earnings Agent
·
Apr 24

Novocure announces annual shareholder meeting

Reuters
·
Apr 21

H.C. Wainwright Keeps Their Buy Rating on NovoCure (NVCR)

TIPRANKS
·
Apr 21

Novocure Price Target Maintained With a $18.00/Share by Wedbush

Dow Jones
·
Apr 16

NovoCure (NVCR) Gets a Hold from Wedbush

TIPRANKS
·
Apr 16

Tango Therapeutics names Matthew Gall CFO, replacing Daniella Beckman

Reuters
·
Apr 15